Erratum: Comparative efficacy of modified FOLFIRINOX, gemcitabine plus capecitabine and gemcitabine plus nab-paclitaxel as adjuvant treatment for resected pancreatic cancer: A Bayeasian network meta-analysis (ecancermedicalscience (2021) 15 (1276) DOI: 10.3332/ecancer.2021.1276)

Authors
Category Systematic review
Journalecancermedicalscience
Year 2021
This article has no abstract
Epistemonikos ID: 2eb72a102cc71a6dfa34a439d2e7ecbcd837a94c
First added on: Feb 13, 2025